Pulmonary Hypertension (PH) Completed Phase 3 Trials for Tadalafil (DB00820)

Also known as: Hypertension, Pulmonary / Pulmonary; Hypertension / Pulmonary hypertension / Hypertension Pulmonary / Pulmonary hypertensions / Pulmonary hypertension NOS

IndicationStatusPhase
DBCOND0051788 (Pulmonary Hypertension (PH))Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00549302Study the Safety and Effectiveness of Tadalafil on High Blood Pressure in the Blood Vessel Going From the Heart to the LungsTreatment
NCT01178073A Study of First-Line Ambrisentan and Tadalafil Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)Treatment
NCT00125918PHIRST-1: Tadalafil in the Treatment of Pulmonary Arterial HypertensionTreatment